NIH VideoCast - Heterogeneity of Breast Cancer Genomes: Going Beyond Therapy to Risk Assessment and Precision Healthcare

Skip Navigation

Heterogeneity of Breast Cancer Genomes: Going Beyond Therapy to Risk Assessment and Precision Healthcare

Loading... Loading video...

329 Views

Air date:	Wednesday, May 25, 2022, 3:00:00 PM Time displayed is Eastern Time, Washington DC Local
Views:	Total views: 329 (121 Live, 208 On-demand)
Category:	WALS - Wednesday Afternoon Lectures
Runtime:	01:06:00
Closed captioning:	Check box to display CC outside of the video Note: You can drag the captioning window around and resize it
Description:	NIH Director’s Wednesday Afternoon Lecture Series This is the annual Marshall W. Nirenberg Lecture. Speaker Olufunmilayo I. Olopade the consummate physician-scientist with sustained and impactful translational research in genetics that spans more than two decades. She is a pioneer in cancer genetics whose body of work has focused on the molecular genetics of breast cancer progression. Her seminal contributions have provided an understanding of the root causes of aggressive breast cancer in young women, especially young women of African ancestry across the Diaspora. Her laboratory was the first to describe recurrent BRCA1 mutations in extended African American families with breast cancer, a study she extended to indigenous Nigerian women in West Africa. Her findings point to the need for women at risk of early-onset aggressive breast cancer across the African diaspora to receive counseling, genetic testing, and personalized screening at younger ages. Dr. Olopade has been recognized for her pioneering work combining medical oncology with cancer genetics in the United States and globally. She has received numerous honors and awards, including several honorary degrees and has an impressive publication record in peer-reviewed journals to her credit. For more information go to https://oir.nih.gov/wals

NLM Title:	Heterogeneity of breast cancer genomes : going beyond therapy to risk assessment and precision healthcare / Olufunmilayo Olopade.
Author:	Olopade, Olufunmilayo I.
Publisher:
Abstract:	(CIT): NIH Directors Wednesday Afternoon Lecture Series. This is the annual Marshall W. Nirenberg Lecture. Speaker Olufunmilayo I. Olopade the consummate physician-scientist with sustained and impactful translational research in genetics that spans more than two decades. She is a pioneer in cancer genetics whose body of work has focused on the molecular genetics of breast cancer progression. Her seminal contributions have provided an understanding of the root causes of aggressive breast cancer in young women, especially young women of African ancestry across the Diaspora. Her laboratory was the first to describe recurrent BRCA1 mutations in extended African American families with breast cancer, a study she extended to indigenous Nigerian women in West Africa. Her findings point to the need for women at risk of early-onset aggressive breast cancer across the African diaspora to receive counseling, genetic testing, and personalized screening at younger ages. Dr. Olopade has been recognized for her pioneering work combining medical oncology with cancer genetics in the United States and globally. She has received numerous honors and awards, including several honorary degrees and has an impressive publication record in peer-reviewed journals to her credit.
Subjects:	Blacks--genetics Health Status Disparities Hereditary Breast and Ovarian Cancer Syndrome--genetics Precision Medicine Treatment Outcome
Publication Types:	Lecture Webcast

NLM Classification:	WP 870
NLM ID:	9918418885706676
CIT Live ID:	44259
Permanent link:	https://videocast.nih.gov/watch=44259

Related Videos...